2024 PARTNERS

Official 2024 Partners - 7th TPD & Induced Proximity Summit

We are proud to have been the definitive event of the year, uniting large pharma, innovative biotech, and world-renowned academics to discuss the full breadth of protein degrader drug development. You can learn more about our official partners for 2023 below.

If you would like to learn more about our bespoke sponsorship opportunities for next year, get in touch today.

Promega

Expertise Partner

See More:

Promega is committed to excellence in technologies and compound profiling services to assess key processes in Targeted Protein Degradation and Induced Proximity mechanisms. From assessing protein degradation in real time, to understanding compound binding and permeability, to ternary complex formation and more. Our CRIPSR HiBiT content covers hundreds of pre-built targets. Novel software analysis tools allow for the determination of target protein degradation rates, DC50 potency values, recovery profiles and more.

www.promega.com

NEOsphere Biotechnologies

Program Partner

See More:

Operating at the forefront of innovation within Munich’s biotech hub, we use cutting-edge mass spectrometry technologies to screen libraries of tens of thousands of compounds against proteomes of more than 10,000 proteins. Our integrated target discovery engine accesses this unprecedented molecular landscape to connect innovative degrader chemistries with the previously undruggable proteome.

www.neospherebiotechnologies.com

SCIEX

Program Partner

See More:

SCIEX offers mass spec and capillary electrophoresis solutions for scientists seeking innovative and reliable analytical experimentation, from routine testing to complex workflows. Our solutions capture the best data, integrate cross-omics results, and deliver relevant insights to enable discovery of key genes, proteins, lipids, and metabolites. With solutions designed by scientists, we empower our customers to transform their workflows and gain more reliable information for their research.

www.sciex.com

Bio-Techne

Program Partner

See More:

LifeSensors, Inc. is a biotechnology company leading the development of innovative research tools and services for the ubiquitin and ubiquitin-like protein pathways. Our unique capability is provide researchers with solutions along every aspect of the ubiquitin proteasome pathway – E3 ligases, DUB enzymes/assays/substrates, ubiquitin chains and mutants, inhibitors, ubiquitin isolation and detection reagents and kits to measure substrate ubiquitylation.

www.lifesensors.com

See More:

BPGbio is a leading biology-first AI-powered clinical stage biopharma focused on mitochondrial biology and protein homeostasis. The company has a deep pipeline of AI-developed therapeutics spanning oncology, rare disease and neurology, including several in late-stage clinical trials. BPGbio’s novel approach is underpinned by NAi, its proprietary Interrogative Biology Platform, protected by over 400 patents; one of the world’s largest clinically annotated non-governmental biobanks with longitudinal samples; and exclusive access to the fastest supercomputer in the world.

www.bpgbio.com

See More:

WuXi AppTec

Innovation Partner

See More:

WuXi AppTec provides a full spectrum of services to support research focused on targeted protein degradation. Our discovery platform allows for in-depth biological and biophysical characterization of bifunctional molecules. We offer proximity assays to measure ternary complex formation, target protein ubiquitination and degradation assays, and high-resolution X-ray crystallography of binary and ternary complexes. Our platform also includes extensive chemistry services, such as custom synthesis, scale-up, and purification of new linkers and E3 ligase ligands.

www.wuxiapptec.com

SAI Life Sciences

Innovation Partner

See More:

Bioduro-Sundia

Exhibiton Partner

See More:

BioDuro-Sundia, an Advent International portfolio company is a trusted, leading contract research development, and manufacturing organization (CRDMO) for over 27 years. We provide our biotech and pharmaceutical partners with fully integrated services to support their efforts from target identification through to commercial drug product manufacturing. The company is based in the US and China and has 10 global sites across 7 cities.

www.biodura-sundia.com

Charnwood Discovery

Exhibition Partner

See More:

Charnwood Discovery is a leading provider of drug discovery services, from standalone customized solutions through to fully integrated programs that enhance the experience and success of complex drug discovery.

Our collaborative and efficient approach ensures we add value across the drug discovery pipeline from target validation through to pre-clinical candidates. Whether you need a standalone or fully integrated solution our multidisciplinary teams provide innovation and excellence at every stage.

www.charnwooddiscovery.com

Nanoimaging Services

Exhibition Partner

See More:

Visualizing biomolecular structures through cryo-EM studies can provide insight into multiple stages of the drug development process, from target identification through formulation and manufacturing. As the industry leader with the longest history in cryo-EM, and with more cryo-EM scientists and TEM microscopes than any provider in North America, NIS is focused on three areas of cutting-edge science: target enablement, characterization, and small molecule microED.

www.nanoimaginingservices.com

Seran Bioscience

Exhibition Partner

See More:

Serán Bioscience is a leading CDMO that specializes in a variety of drug delivery and formulation approaches suited to optimizing bioavailability. Serán’s experienced teams will work with you to identify an appropriate formulation strategy to meet your program’s unique needs.

Serán's team comprehensively evaluate technologies to consider bio-performance, stability, manufacturability, and drug product design – aiming to develop scalable formulations using efficient and material-sparing approaches.

Serán provides capsules, tablets, multi-particulates, and powder-in-bottle formulations.

www.seranbio.com

NanoTemper

Exhibition Partner

See More:

Biotheryx

Event Partner

See More:

Biotheryx is a clinical stage biopharmaceutical company discovering and developing a portfolio of innovative small molecule targeted protein degraders (TPDs) for the treatment of a wide range of diseases with an initial focus on cancer. Members of our founding and scientific teams previously developed the first Food and Drug Administration (FDA) approved modulators of Cereblon, the most widely validated E3 ligase involved in protein degradation, and have applied their expertise in Cereblon binding to build our proprietary PRODEGY platform

www.biotheryx.com

Orionis Biosciences

Industry Partner

See More:

Orionis Biosciences is a life sciences company pioneering technological innovation in genome-scale drug discovery and tunable molecular design of novel therapeutic drug modalities. Our technologies and pipeline include proprietary A-Kine™ biologics and Allo-Glue™ small molecule platforms with broad, innovative applications to the reprogramming of disease states. The company is currently advancing multiple novel immunotherapies for the treatment of cancer.

www.orionisbio.com

Biortus

Exhibition Partner

See More:

Biortus is a structure-based drug discovery CRO with a mature protein focused lead generation platform including modular services in protein production, assay development, fragment screening, and structure determination in microED, CryoEM, and X-ray crystallography. We’ve solved structures of some ternary degradation complexes including VHL and CRBN based PROTACs. Our newest Boston site is available for 2-way sample shipment and serves as the headquarters for our off-the-shelf Protein Catalog which includes DUBS, E3 ligases, and more.

www.en.wuxibiortus.com

DEEPKINASE

Event Partner

See More:

DeepKinase pioneers in proteomics for drug discovery and development, with two leading products, DoTD and DoTK.

DoTD provides mass spectrometry based quantitative proteomics to assist TPD therapeutics; results are featured in numerous IND filings.

DoTK offers patented tyrosine phosphoproteomics technology, vital to understand kinase activities and signaling in cancer and immune diseases.

DeepKinase is a global front-runner in proteomics analysis, driving novel research, biomarker discovery, and personalized medicine in pharmaceutical industry.

www.deepkinase.com

FULL EVENT GUIDE

PARTNER

October 28-31 2024 I Boston, MA

⭐World’s Largest, Longest-Standing
TPD & Induced Proximity Forum

2024 PARTNERS

Official 2024 Partners - 7th TPD & Induced Proximity Summit

Promega

NEOsphere Biotechnologies

SCIEX

Bio-Techne

WuXi AppTec

SAI Life Sciences

Bioduro-Sundia

Charnwood Discovery

Nanoimaging Services

Seran Bioscience

NanoTemper

Biotheryx

Orionis Biosciences

Biortus

DEEPKINASE

VENUE

LOCATION

OUR CONTACT DETAILS

JOIN OUR TEAM

ABOUT US

EXPLORE OUR PRODUCTS

SEARCH

October 28-31 2024 I Boston, MA

⭐World’s Largest, Longest-Standing TPD & Induced Proximity Forum

2024 PARTNERS

Official 2024 Partners - 7th TPD & Induced Proximity Summit

Promega

NEOsphere Biotechnologies

SCIEX

Bio-Techne

LifeSensors

BPGbio

Nuclera

WuXi AppTec

SAI Life Sciences

Bioduro-Sundia

Charnwood Discovery

Nanoimaging Services

Seran Bioscience

NanoTemper

Biotheryx

Orionis Biosciences

Biortus

DEEPKINASE

VENUE

LOCATION

OUR CONTACT DETAILS

JOIN OUR TEAM

ABOUT US

EXPLORE OUR PRODUCTS

SEARCH

⭐World’s Largest, Longest-Standing
TPD & Induced Proximity Forum